WallStreetZenWallStreetZen

NYSE: IBER
Ibere Pharmaceuticals Stock

Open Broker Account
$9.92+0.00 (+0%)
Updated Oct 4, 2022
IBER Price
$9.92
Fair Value Price
N/A
Market Cap
$171.12M
52 Week Low
$9.68
52 Week High
$9.94
P/E
27.56x
P/B
-29.05x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$7.13M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.05
Operating Cash Flow
-$770k
Beta
0
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

Industry Average (11)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how IBER scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

IBER is good value based on its earnings relative to its share price (27.56x), compared to the US market average (29.05x)
P/E vs Market Valuation
IBER is good value based on its earnings relative to its share price (27.56x), compared to the US Shell Companies industry average (-5.4x)
P/E vs Industry Valuation
IBER's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more IBER due diligence checks available for Premium users.

Be the first to know about important IBER news, forecast changes, insider trades & much more!

IBER News

Valuation

IBER price to earnings (PE)

For valuing profitable companies with steady earnings
Company
27.56x
Industry
-5.4x
Market
29.05x
IBER is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
IBER is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

IBER price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-29.05x
Industry
-33x

IBER's financial health

Profit margin

Revenue
$0.0
Net Income
$1.5M
Profit Margin
0%
IBER's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$138.4M
Liabilities
$6.2M
Debt to equity
-1.05
IBER's short-term liabilities ($398.01k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IBER's long-term liabilities ($5.77M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IBER's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
IBER's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$200.6k
Investing
$0.0
Financing
$158.9k
IBER's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

IBER vs Shell Company Stocks

TickerMarket Cap1d %P/EP/B
IBER$171.12M0.00%27.56x-29.05x
KORE$172.30M+8.13%-3.96x0.65x
JATT$173.54M+0.10%13.06x-25.23x
CNTQ$168.09M+3.30%354.33x-417.25x
MURF$174.41M-0.10%N/A-52.93x

Ibere Pharmaceuticals Stock FAQ

What is Ibere Pharmaceuticals's quote symbol?

NYSE: IBER) Ibere Pharmaceuticals trades on the NYSE under the ticker symbol IBER. Ibere Pharmaceuticals stock quotes can also be displayed as NYSE: IBER.

If you're new to stock investing, here's how to buy Ibere Pharmaceuticals stock.

What is the 52 week high and low for Ibere Pharmaceuticals (NYSE: IBER)?

(NYSE: IBER) Ibere Pharmaceuticals's 52-week high was $9.94, and its 52-week low was $9.68. It is currently -0.2% from its 52-week high and 2.48% from its 52-week low.

How much is Ibere Pharmaceuticals stock worth today?

(NYSE: IBER) Ibere Pharmaceuticals currently has 17,250,000 outstanding shares. With Ibere Pharmaceuticals stock trading at $9.92 per share, the total value of Ibere Pharmaceuticals stock (market capitalization) is $171.12M.

Ibere Pharmaceuticals stock was originally listed at a price of $10.05 in Feb 26, 2021. If you had invested in Ibere Pharmaceuticals stock at $10.05, your return over the last 1 years would have been -1.29%, for an annualized return of -1.29% (not including any dividends or dividend reinvestments).

How much is Ibere Pharmaceuticals's stock price per share?

(NYSE: IBER) Ibere Pharmaceuticals stock price per share is $9.92 today (as of Oct 4, 2022).

What is Ibere Pharmaceuticals's Market Cap?

(NYSE: IBER) Ibere Pharmaceuticals's market cap is $171.12M, as of Oct 5, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Ibere Pharmaceuticals's market cap is calculated by multiplying IBER's current stock price of $9.92 by IBER's total outstanding shares of 17,250,000.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.